Table 3. Uni- and multivariate analyses of rpS6 and p-rpS6 expression and clinical/pathologic features for the prediction of cancer specific survival in patients with RCCs.
Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
Hazard Ratio (95 % CI) | p | Hazard Ratio (95 % CI) | p | |
rpS6 & p-rpS6 | 1.7 (1.3-2.3) | <0.001 | 1.9 (1.4-2.6) | <0.001 |
Karnofsky* | 2.6 (1.9-3.4) | <0.001 | 1.6 (1.2-2.2) | 0.002 |
Tumor extent◦ | 5.7 (4.2-7.8) | <0.001 | 2.9 (2-4.2) | <0.001 |
Regional lymph node metastasis• | 7.1 (4.9-10.1) | <0.001 | 1.6 (1.1-2.4) | 0.03 |
Distant metastasis± | 10.6 (7.7-14.4) | <0.001 | 5.1 (3.5-7.3) | <0.001 |
Grade of malignancy⊗ | 5.4 (3.9-7.3) | <0.001 | 1.8 (1.3-2.5) | 0.001 |
Type of surgeryt | 4.5 (2.1-9.7) | <0.001 | 1.9 (0.9-4.3) | 0.10 |
Sex = | 1.6 (1.2-2.2) | 0.003 | 1.3 (0.9-1.8) | 0.15 |
Histopathologic subtype< | 1.6 (1.2-2.2) | 0.003 | 1.2 (0.7-1.9) | 0.5 |
p-rpS6 Expression∗ | 1.9 (1.4-2.6) | <0.001 | 1.4 (1-1.9) | 0.03 |
Karnofsky* | 2.3 (1.8-3) | <0.001 | 1.7 (1.3-2.2) | <0.001 |
Tumor extent◦ | 5.6 (4.2-7.5) | <0.001 | 2.8 (2-3.8) | <0.001 |
Regional lymph node metastasis• | 6.8 (4.9-9.5) | <0.001 | 1.7 (1.2-2.5) | 0.006 |
Distant metastasis± | 10.8 (8.1-14.4) | <0.001 | 5 (3.6-7) | <0.001 |
Grade of malignancy⊗ | 5.3 (4-7) | <0.001 | 1.9 (1.4-2.6) | <0.001 |
Type of surgeryt | 3.4 (1.9-6) | <0.001 | 1.2 (0.7-2.3) | 0.51 |
Sex = | 1.6 (1.2-2.2) | 0.001 | 1.4 (1-1.9) | 0.04 |
Histopathologic subtype< | 1.6 (1.2-2.2) | 0.001 | 1.1 (0.7-1.8) | 0.56 |
rpS6 Expression∗ | 1.8 (1.4-2.4) | <0.001 | 1.8 (1.4-2.4) | <0.001 |
Karnofsky* | 2.5 (1.9-3.2) | <0.001 | 1.7 (1.3-2.3) | <0.001 |
Tumor extent◦ | 5.9 (4.3-7.9) | <0.001 | 2.8 (2-3.9) | <0.001 |
Regional lymph node metastasis• | 5.9 (4.2-8.3) | <0.001 | 1.4 (0.9-2) | 0.13 |
Distant metastasis± | 10.3 (7.7-13.8) | <0.001 | 4.9 (3.5-6.8) | <0.001 |
Grade of malignancy⊗ | 5.8 (4.3-7.7) | <0.001 | 1.9 (1.4-2.6) | <0.001 |
Type of surgeryt | 5 (2.4-10.1) | <0.001 | 1.9 (0.9-3.9) | 0.1 |
Sex = | 1.6 (1.2-2.2) | 0.001 | 1.5 (1.1-2) | 0.015 |
Histopathologic subtype< | 1.6 (1.2-2.2) | 0.001 | 1.1 (0.7-1.8) | 0.6 |
Immunistochemical intensity low vs. high
<80% vs >= 80%
pT3/pT4 vs pT1/pT2
pN1/pN2 vs pN0/N0
M0 vs M1
G1/G2 vs G3/G4
Male vs female
Radical vs partial nephrectomy
Clear-cell (conventional) vs other types